ID: ALA1818307

Max Phase: Preclinical

Molecular Formula: C16H17N4NaO8S3

Molecular Weight: 490.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S(=O)([O-])OCc1cn([C@H]2[C@@H](O)[C@@H](CO)O[C@@H](Sc3nc4ccccc4s3)[C@@H]2O)nn1.[Na+]

Standard InChI:  InChI=1S/C16H18N4O8S3.Na/c21-6-10-13(22)12(20-5-8(18-19-20)7-27-31(24,25)26)14(23)15(28-10)30-16-17-9-3-1-2-4-11(9)29-16;/h1-5,10,12-15,21-23H,6-7H2,(H,24,25,26);/q;+1/p-1/t10-,12+,13+,14-,15+;/m1./s1

Standard InChI Key:  LNPUSSLAYSMYPF-TULOUXPUSA-M

Associated Targets(Human)

Galectin-9 186 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 490.54Molecular Weight (Monoisotopic): 490.0287AlogP: -0.02#Rotatable Bonds: 7
Polar Surface Area: 177.12Molecular Species: ACIDHBA: 13HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: -2.23CX Basic pKa: 0.90CX LogP: -1.78CX LogD: -1.84
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.33Np Likeness Score: -0.47

References

1. Giguère D, André S, Bonin MA, Bellefleur MA, Provencal A, Cloutier P, Pucci B, Roy R, Gabius HJ..  (2011)  Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins.,  19  (10): [PMID:21524586] [10.1016/j.bmc.2011.03.022]

Source